Three Seasons Wealth LLC Reduces Stock Position in Lam Research Corporation $LRCX

Key Points

• Three Seasons Wealth LLC reduced its Lam Research position by 71.1% in the second quarter, selling 16,850 shares and retaining 6,854 shares valued at approximately $2.97 million. Institutional investors still own 84.61% of the company.
• Lam Research exceeded quarterly expectations with $6.72 billion in revenue and $1.82 EPS, while revenue rose 30% year over year. The company also raised its quarterly dividend by approximately 27% to $0.33 per share.
• Analysts maintain a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $358.97, although several firms recently lowered their targets and insiders have reported stock sales.

Three Seasons Wealth LLC cut its position in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 71.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,854 shares of the semiconductor company's stock after selling 16,850 shares during the period. Three Seasons Wealth LLC's holdings in Lam Research were worth $2,970,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Bayban purchased a new position in Lam Research during the 4th quarter worth approximately $26,000. Vermillion Wealth Management Inc. acquired a new stake in Lam Research during the 1st quarter valued at approximately $26,000. Cedar Mountain Advisors LLC boosted its holdings in shares of Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after acquiring an additional 85 shares during the last quarter. Paladin Partners LLC purchased a new stake in shares of Lam Research in the 2nd quarter valued at $26,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in shares of Lam Research in the fourth quarter worth $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Trading Up 5.1%

Shares of Lam Research stock opened at $307.65 on Friday. The stock has a 50 day moving average of $321.34 and a 200 day moving average of $291.39. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The firm has a market capitalization of $384.97 billion, a price-to-earnings ratio of 53.41, a PEG ratio of 1.16 and a beta of 1.85. Lam Research Corporation has a fifty-two week low of $100.68 and a fifty-two week high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.69 by $0.13. The firm had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. Lam Research's revenue was up 30.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, research analysts predict that Lam Research Corporation will post 9.33 earnings per share for the current year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be issued a $0.33 dividend. The ex-dividend date is Wednesday, September 23rd. This represents a $1.32 annualized dividend and a dividend yield of 0.4%. This is a boost from Lam Research's previous quarterly dividend of $0.26. Lam Research's dividend payout ratio (DPR) is presently 18.06%.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
• Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
• Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
• Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
• Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
• Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
• Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on LRCX shares. Morgan Stanley reduced their target price on shares of Lam Research from $404.00 to $367.00 and set an "overweight" rating for the company in a report on Thursday, July 30th. UBS Group lowered their price target on Lam Research from $435.00 to $425.00 and set a "buy" rating on the stock in a research report on Tuesday. Bank of America lifted their target price on shares of Lam Research from $330.00 to $480.00 and gave the company a "buy" rating in a research report on Tuesday, June 23rd. B. Riley Financial dropped their price target on Lam Research from $385.00 to $350.00 and set a "buy" rating for the company in a research report on Thursday, July 30th. Finally, Susquehanna reissued a "positive" rating and issued a $475.00 price target (up from $385.00) on shares of Lam Research in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Lam Research has a consensus rating of "Moderate Buy" and an average price target of $358.97.

Insider Transactions at Lam Research

In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the sale, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $302.46, for a total value of $1,512,300.00. Following the completion of the sale, the insider directly owned 42,462 shares in the company, valued at $12,843,056.52. This represents a 10.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 77,782 shares of company stock valued at $26,755,370. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source